Q: CMV Retinitis can be treated by ganciclovir or foscarnet,
A) orally,
B) intravenously,
C) intravitreal injection
D) intravitreal implant
E) All of the above.
A) orally,
B) intravenously,
C) intravitreal injection
D) intravitreal implant
E) All of the above.
Answer: E (all of the above)
Beside regular route of administration it is interesting to note that the Vitrasert ganciclovir implant is a sustained-release intravitreal implant that is used for the treatment of cytomegalovirus (CMV) retinitis. Each implant is designed to release drug over a 5 to 8 month period.
